These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2218964)

  • 1. [Monitoring of therapy using drug concentration levels: Why? When? How?].
    Vozeh S
    Ther Umsch; 1990 Aug; 47(8):635-9. PubMed ID: 2218964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles].
    Klotz U
    J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy in childhood: what has been done and what has to be done?
    Bartels H
    Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indicative therapeutic and toxic drug concentrations in plasma: a tabulation.
    Meyer FP
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):71-81. PubMed ID: 8004362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primer on clinical pharmacokinetics.
    Bauer LA
    Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic drug monitoring with the help of serum concentration measurements. How are the analytic results distributed in a population?].
    Skomedal T; Osnes JB; Johannessen SI; Lund PK; Aass H
    Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2242-6. PubMed ID: 8362387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.
    Khot V; DeVane CL; Korpi ER; Venable D; Bigelow LB; Wyatt RJ; Kirch DG
    J Clin Psychopharmacol; 1993 Apr; 13(2):120-7. PubMed ID: 8463444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Absorption and biological availability of drugs].
    Uribe M
    Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misuse of therapeutic drug monitoring: an analysis of causes and methods for improvement.
    Travers EM
    Clin Lab Med; 1987 Jun; 7(2):453-72. PubMed ID: 3301179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic and toxic blood concentrations of more than 500 drugs.
    Schulz M; Schmoldt A
    Pharmazie; 1997 Dec; 52(12):895-911. PubMed ID: 9442555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Input rate-dependent stereoselective pharmacokinetics: effect of pulsatile oral input.
    Mehvar R
    Chirality; 1994; 6(3):185-95. PubMed ID: 8024949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug accumulation and dose finding (authors' transl)].
    Kurz H
    Arzneimittelforschung; 1977 Feb; 27(2A):250-3. PubMed ID: 577170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal changes in aging and nursing implications of drug therapy.
    Hayes JE
    Nurs Clin North Am; 1982 Jun; 17(2):253-62. PubMed ID: 6919935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of patient compliance on drug concentration profile in multiple doses.
    Wang W; Husan F; Chow SC
    Stat Med; 1996 Mar; 15(6):659-69. PubMed ID: 8731007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness of sampling times for therapeutic drug monitoring.
    Mason GD; Winter ME
    Am J Hosp Pharm; 1984 Sep; 41(9):1796-801. PubMed ID: 6496515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring. Pharmacokinetics.
    Taylor WJ
    Am J Med Technol; 1983 Aug; 49(8):557-63. PubMed ID: 6670671
    [No Abstract]   [Full Text] [Related]  

  • 19. Using pharmacokinetics in drug therapy. VII: Pharmacokinetic factors influencing drug therapy in the aged.
    Schumacher GE
    Am J Hosp Pharm; 1980 Apr; 37(4):559-62. PubMed ID: 6990755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.